Principal Investigator
|
Title
|
Organization
|
Status
|
ID
|
| Battegay, Manuel E. |
Intolerance and toxicity to antiretroviral therapy leading to treatments switch or discontinuation within the SHCS |
Infektiologie (Battegay M) |
Completed |
1201689 |
| Battegay, Manuel E. |
Impact of antibiotic consumption on the epidemiology of Clostridium difficile infections 2004-2008 in a Swiss tertiary hospital |
Infektiologie (Battegay M) |
Completed |
1201252 |
| Flückiger, Ursula M. |
Detection of Epidemic Hypervariable Staphylococcus epidermidis strains in the University Hospital Basel in general and in a high risk unit for haematological patients |
Infektiologie (Battegay M) |
Completed |
1201234 |
| Battegay, Manuel E. |
Antagonists of Type 1 Fimbriae-mediated Adhesion of Escherichia coli: Treatment of Urinary Tract Infections |
Infektiologie (Battegay M) |
Completed |
1201253 |
| Battegay, Manuel E. |
Determinants of virological suppression in antiretroviral-treated patients with self-reported poor adherence |
Infektiologie (Battegay M) |
Completed |
1201690 |
| Battegay, Manuel E. |
Schweiz. HIV-Kohorten Studie (inkl. Swiss Mother & Child Cohort Study) |
Infektiologie (Battegay M) |
Completed |
1201691 |
| Elzi, Luigia |
Determinants of the choice of fistline antiretroviral treatment in HIV-infected individuals |
Infektiologie (Battegay M) |
Completed |
1201424 |
| Elzi, Luigia |
Combination antiretroviral therapy in HIV-infected women participating in the Swiss HIV Cohort Study |
Infektiologie (Battegay M) |
Completed |
1201425 |
| Widmer, Andreas F.-X. |
Direct Toxin positive Clostridium difficile cases versus patients with positive toxigenic cultures: Impact on patient outcome and difference in growth patterns by microcalorimetry |
Infektiologie (Battegay M) |
Completed |
1201313 |
| Battegay, Manuel E. |
Combination antiretroviral therapy in HIV-infected women participating in the Swiss HIV Cohort Study |
Infection Biology (Battegay M) |
Completed |
1201512 |
| Battegay, Manuel E. |
Determinants of the choice of the initial combination antiretroviral therapy in treatment-naive HIV-infected individuals |
Infection Biology (Battegay M) |
Completed |
1201514 |
| Battegay, Manuel E. |
Effect of SLCO1B1 521T>C polymorphism on the lipid-lowering response to statins in HIV-infected patients treated with lopinavir/r containing regimens |
Infection Biology (Battegay M) |
Completed |
1201511 |
| Battegay, Manuel E. |
Effect of SLCO1B1 521T>C polymorphism on the lipid-lowering response to statins in HIV-infected patients treated with lopinavir/r containing regimens |
Infection Biology (Battegay M) |
Completed |
1201513 |
| Battegay, Manuel E. |
Gender differences in combination antiretroviral therapy in HIV-infected individuals participating in the Swiss HIV Cohort Study |
Infection Biology (Battegay M) |
Completed |
1201510 |
| Battegay, Manuel E. |
Risk of progression to AIDS or death in relation to CD4 cell levels in HIVinfected patients with sustained viral response to cART |
Infection Biology (Battegay M) |
Completed |
1201509 |
| Weisser, Maja; Labhardt, Niklaus; Burkard, Thilo |
Identifying most effective Treatment Strategies to control Arterial Hypertension in sub-Saharan Africa - A Randomized Controlled Trial |
Faculty of Medicine,
Departement Biomedizin / Department of Biomedicine, University Hospital Basel,
Bereich Medizinische Fächer (Klinik) / Infektiologie (Battegay M) |
Completed |
4500627 |
| Khanna, Nina |
Relevance of different CD4+ Tcell subsets for antifungal defense. What is aberrant in immunocompromised patients?" |
Departement Biomedizin / Infection Biology (Khanna) |
Completed |
1291394 |
| Osthoff, Michael |
Significance of mannose-binding lectin and the lectin pathway in acute and recurrent ischemia/repefusion injury |
Departement Biomedizin / Clinical Immunology (Trendelenburg),
Bereich Medizinische Fächer (Klinik) / Infektiologie (Battegay M) |
Completed |
2561133 |
| Osthoff, Michael |
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of critical SARS-CoV-2 infection in hospitalized patients with COVID-19: a randomized, parallel-group, openlabel, multi-center exploratory trial. NFP 78 |
Departement Biomedizin / Clinical Immunology (Trendelenburg),
Bereich Medizinische Fächer (Klinik) / Infektiologie (Battegay M) |
Completed |
4601485 |
| Flückiger, Ursula M. |
Analysis of Infectious at the Hematological Unit of the University Hospital |
Bereich Medizinische Fächer (Klinik) / Infektiologie (Battegay M) |
Completed |
1201814 |
